Letters to the Editor
Vol. 16 No. 1 (2024): Review Articles, Original Article, Scientific Letter, Case Reports Letter to the Editor
Is there a better therapeutic time window from diagnosis to treatment elderly acute myeloid leukemia patients receiving hypomethylating agents?
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: March 3, 2024
Accepted: May 18, 2024
Accepted: May 18, 2024
610
Views
771
Downloads
70
HTML
Authors
Downloads
Download data is not yet available.
Citations
How to Cite
“Is there a better therapeutic time window from diagnosis to treatment elderly acute myeloid leukemia patients receiving hypomethylating agents?” (2024) Mediterranean Journal of Hematology and Infectious Diseases, 16(1), p. e2024055. doi:10.4084/MJHID.2024.055.
Copyright (c) 2024 Salvatore Perrone
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
